[PSI] strains ͉ amyloid ͉ Sup35 A myloid is a generic class of ordered protein aggregates self-assembled by many unrelated proteins (1). X-ray diffraction studies reveal that amyloid fibers are rich in ␤-strands, which run perpendicular to the fiber axis, forming the characteristic cross-␤ pattern (2). One of the most intriguing features of the amyloid is structural polymorphism, whereby the same protein polypeptide can adopt distinct chain-folding patterns to give rise to a variety of cross-␤ structures (3). Structural plasticity of the amyloid underlies the prion strain phenomenon. Selfnucleating amyloid conformers faithfully maintain their distinct folds in the host but sometimes can adjust their structures when encountering different sequences (such as during interspecies transmission), thus giving rise to novel prion strains (4, 5). It is not well understood how distinct cross-␤ folding patterns are determined and what is the mechanism for their interconversion.
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The yeast prion [PSI] is a self-propagating amyloid aggregate of Sup35, the yeast translation-termination factor whose aggregation in the [PSI ϩ ] state results in enhanced read-through of nonsense mutations (6, 7) . Structural polymorphism of Sup35 amyloids gives rise to [PSI] strains that exhibit distinctive nonsense-suppression efficiencies and differential compatibility with Sup35 mutations (8) (9) (10) (11) . With the ease of biochemical and genetic manipulation, [PSI] strains provide excellent experimental systems to study amyloid polymorphism. However, because in vitro assembled amyloid samples often contain multiple fiber morphologies, great care must be taken to ensure correct interpretation of experimental results. Attributing genetic observations to pure structural causes, however, is complicated by the interplay between amyloid structures and cellular machineries. Here, we design a synthesized approach to avoid these difficulties, combining biochemistry and yeast genetics to examine the amyloid structures of three [PSI] strains: [VH] , [VK] , and [VL] (11) . By individually substituting residues 5-55 of Sup35 with proline and inserting glycine in front of every other residue in this segment, we identify strain-specific Sup35 sequences in vivo. The necessity of these sequences for encoding infectious prion structures is then investigated by infecting yeast with amyloid fibers of Sup35 fragments assembled in vitro. Our goal is to define the minimally required Sup35 sequences that form core structures of the three [PSI] strains to understand how the same polypeptides are recruited in different ways to assemble polymorphic amyloid structures.
Results
Proline Substitutions. We employ proline substitutions to map possible ␤-structures along the polypeptide chain. Proline residues with the unique cyclic structure generate bulges in ␤-strands and destabilize periodic amyloid structures. A panel of 51 [psi Ϫ ] haploid mutants, each having a single proline substitution in the amino acid residues 5-55 of the SUP35 allele, was created by homologous recombination. The proline substitution mutants were mated with WT cells carrying different prion strains. We first used GFP labeling to examine whether [PSI] was maintained in the resulting heterozygotes (12) . [PSI ϩ ] heterozygotes were then sporulated to determine whether mutant haploids alone could support the propagation of the prion strain (i.e., preserve the infectious structure of the Sup35 amyloid). Our data revealed that each prion strain required a unique continuous Sup35 segment to propagate in vivo, which was destroyed by proline substitutions (Fig. 1A) . For the [VH] strain, this segment extended from residues 7-21. Proline substitutions at most of the residues afterward weakened the nonsense suppression, but still maintained the characteristics of the [VH] strain. The [VK] segment was composed of amino acid residues 9-37. The required segment of the [VL] strain started from our first mutated residue (residue 5) and ran until the end (residue 52). Biochemical experiments below (see Table 1 ) indicate the [VL] segment might run even longer to at least residue 61.
Insertion of a glycine residue in a ␤-strand would either alter the orientation of amino acid side chains after the insertion site or generate a bulge at the insertion. Both destabilize the amyloid structure. The strain-specific segments independently revealed by glycine insertions were in striking accordance with the proline substitution data (Fig. 1B) . We further observed that glycine insertions in front of amino acids 25 and 27 strengthened the nonsense suppression efficiency of [VK] without affecting other [VK] characteristics. The data suggest relaxation of the [VK] structure at positions 25-27, thus dividing the [VK] segment into two ''arms.'' Specific Thioflavin T (ThT) Affinity. To provide independent evidence for the size difference of strain-specific sequences, we measured specific ThT binding affinities to amyloid fibers of the three prion strains. Infectious prion particles were affinitypurified from yeast by labeling with Sup (1-61)-GFP containing an attached C-terminal purification tag (8) . Amyloid fibers were then prepared by adding the yeast particles to recombinant Sup (1-61)-GFP solutions that were shown previously to support in vitro propagation of prion infectivity (8) . ThT binding to the fibers resulted in red shift of the fluorescence emission maximum, as expected for amyloids (13 (Fig. 2) . (Fig. 3B) . The sigmoidal kinetics suggested that a fast-growing fiber conformation built up in the solution and dominated the population. The new conformation had diminished infectivity because the Sup (11-61)-GFP specimen was determined to have lower specific infectivity in comparison with a Sup (1-61)-GFP specimen prepared in parallel (Fig. 3C ).
Minimal Fragments to Encode Prion Infectivity. We next determine whether the strain-specific sequences revealed by proline substitution and glycine insertion experiments in vivo are necessary to encode infectious prion strain conformations. We used purified Sup (1-61)-GFP decorated yeast prion particles to nucleate amyloid fibers in vitro from recombinant Sup35 fragments, and then determined the infectivity of the fibers. Sup35 fragments were C-terminally tagged with GFP to enhance solubility and to facilitate real-time monitoring of the seeding process. For the (Fig. 1) . The Sup (1-40)-GFP fibers had a jagged shape (Fig. 4C) . When used to seed Sup (1-61)-GFP, the resulting fibers returned to the normal wavy morphology (Fig. 4 B and D) , indicating that the intrinsic structural order was faithfully maintained through the passages. Sup(1-27)Gly 13 Strain Dominance and Genetic Backgrounds. Prion strains are in metastable states. The efficiency of their cellular propagation is kinetically determined where the fastest multiplicating, truebreeding structures dominate. We previously suggested that the cellular frangibility of prion fibers played an important role in determining the strength of a prion strain (14) . This notion was born out by a beautiful full treatment in Tanaka (Fig. S2) . This genetic background effect makes clear that the competitive effectiveness of a prion strain is modulated by the host's genetic environment in addition to the intrinsic physical properties of its fiber. The molecular mechanism of host modulation remains to be determined.
Discussion
The minimal polypeptide lengths revealed here reconfirm our previous results that the first 61 residues of Sup35 are sufficient to encode the three prion strain conformations in vitro (8) . The strain-specific segment of our strong [VH] strain defined in vivo (residues 7-21) differs from the strong strain amyloid core proposed by Toyama et al. (16) . The discrepancy could result from structural variability of in vitro assembled fibers used in the study of Toyama et al. (16) . Sup (1-61)-GFP fiber specimens that impart [VH] phenotypes contain two major morphologies, lanky and hunky, whose mass-per-fiber-length measurements correspond to Ϸ1 and 1.17 prion molecules per 4.7 Å cross-␤ repeat distance, respectively (14) . The biphasic hydrogen exchange kinetics, reported by Toyama et al. (16) for the strong strain, could reflect similar dimorphism in their samples. In addition, the biphasic kinetics might indicate multiple structural environments within the same fiber as suggested by Toyama et al. (16) . Tacking of extra prion molecules along a periodic cross-␤ core was proposed to cause the hunky fiber morphology, which would give rise to multiple environments for identical amino acid residues (14). It is not yet known whether the lanky and hunky fibers are equally infectious and interconvertible.
Nelson et al. (17) demonstrated Sup (7-13) peptide was able to form amyloid-like ''steric-zipper'' structures (18) . In such structures, extended Sup (7-13) peptides stack parallel to the one below along the fiber axis to form a ␤-sheet. Two identical sheet surfaces then ''zip-up'' face-to-face by side chain interdigitation. In a [PSI] strain, the strain-specific segment (Fig. 1 ) might adopt a sinuous folding pattern consisting of few straight ␤-strands (14, (19) (20) (21) (22) . Each ␤-strand aligns with its counterpart in the polypeptide unit below via hydrogen bonds. ␤-sheets composed of neighboring strands then zip together to give the strain structure. Alternatively, assembly of three neighboring ␤-sheets to form a triangular ␤ solenoid is possible, as it was observed in a recently determined structure of the HET-s prion (23) . The models predict that mass-per-fiber-length measurement yields a value close to one Sup35 polypeptide mass per Ϸ4.7 Å repeat distance. This was indeed observed for the lanky fibers of the [VH] and [VL] strains (14) . The wavy [VK] fiber has a measurement of 1.15 polypeptide mass per 4.7 Å. Tilting of ␤-sheets by Ϸ30 o to make a helix would require systemic rotation of vertically aligned ␤-segments, disrupting the tight stericzipper configuration (14) .
In this study, we focus on minimally required Sup35 fragments that are sufficient to encode infectious amyloid structures in vitro. It is known from genetic experiments that the minimal length to impart infectivity (defined here by yeast transformation experiments) is not sufficient to maintain cellular propagation of [PSI] strains (24, 25) . There is additional evidence to indicate that amino acid residues following Sup (1-61) contribute to fiber structures (11, 16, 20, 26) . The extra polypeptide length might be [VH] requires longer polypeptide fragments than the strain-specific core segment defined by proline substitution mutagenesis to stabilize the infectious conformation, which otherwise has propensity to transmute to noninfectious structures [revealed here by seeding Sup and Sup (1-47)]. This study provides a general experimental strategy for focusing on the structures of biologically relevant amyloid species and avoiding complications in data interpretation caused by structural heterogeneity in the sample. The approach can be applied to other natural and artificial yeast prions to establish general principles of amyloid structural polymorphism. Such knowledge would help the determination of prion strain structures at atomic resolution and further aid the design of interesting amyloid-like structures for novel applications (27, 28) .
Materials and Methods
Yeast Strains, General Methods, and PCR Primers. All genetic experiments were performed in the 5V-H19 genetic background (MATa Table S1 .
Proline Substitutions and Glycine Insertions. YCp-I-SUPF and YIp-I-SUPN (11) containing the 1243-bp SUP35 promoter, followed by a BamHI restriction site and then the SUP35 coding sequence, were subjected to site-directed mutagenesis by using the QuikChange II kit (Stratagene) to generate proline substitution and glycine insertion mutations. Mutant plasmids were used as templates for PCR amplification of SUP35 sequences, using primers CYK-43 and CYK-2. The PCR products were cotransformed with YCplac111 (33) into yeast g␣5V-H19-Prp⌬SF to select red colonies on SC-LEU agar plates. For each mutation, two independent red colonies were isolated and verified by BamHI/ BstXI digestion of genomic PCR products, by using primers CYK-43 and CYK-15 and sequencing the first 372 bp of the SUP35 coding sequence. ) independent red diploids were transformed and observed, and PNM was assigned only when all of the diploids showed Ͻ5% labeling.
Red ASN diploids as well as white and pink diploids, were subjected to random sporulation to select his Ϫ spores for further analysis (eliminating surviving diploid cells). Spores of each mutation were grouped as white, pink, dark pink, and red, according to the colony color. We determined which color group was specifically associated with the mutation. Four colonies of each color group were analyzed for allotype by BamHI digestion of a SUP35(Ϫ1243-372) genomic PCR fragment (primers CYK-43 and CYK-15). Mutant alleles were distinguished from the WT by the unique BamHI restriction site located before the first codon. The [PSI] compatibility of each mutant was then scored by the colony color (the WT color ϭ 1; red ϭ 0; whiter than WT Ͼ 1; darker than WT Ͻ 1, [ϩ] cells), which was indicative of [PSI] strength in the 5V-H19 genetic background (11) . Mutations with compatibility scores that were not 0 or 1 were further strain-typed by strain-specific GFP labeling using Sup (1-61)-GFP, Sup (1-61)(G20D)-GFP, and Sup (1-61)(Q23P)-GFP (12) (two independent colonies). We did not observe strain type changes in all occasions. For each mutation, the whole experiment was performed for two independently isolated colonies. Consistent results were obtained. To monitor the time course of fiber formation, recombinant proteins were diluted in 3 ml of buffer containing 12.5 M ThT, 50 mM Tris⅐HCl, 25 mM Glycine, and 0.5 mM EDTA (pH 8.0). Twenty microliters of yeast seeds were added to the solution and mixed gently. Seeding reactions were monitored at 25°C and undisturbed for 72 h, except that, before each measurement, sealed cuvettes were gently reverted once to redistribute the fibers. Protein solutions mock-seeded with Buffer E were included as controls. (Table S1 ) to obtain the YIp-I-SUPN⌬ (5-10) and YIp-I-SUPN⌬ (5-20) plasmids, respectively. The plasmids were then used as templates for PCR amplification of SUP35 sequences, using primers CYK-43 and CYK-2. The PCR products were cotransformed with YCplac111 (33) into yeast g␣5V-H19-Prp⌬SF to select red colonies on SC-LEU agar plates. For each derivative, two independent red colonies were isolated and verified by sequencing genomic PCR products (primers CYK-43 and CYK-15).
To 
Sup35
Fragments. DNA encoded Sup35 fragments were amplified by PCR using YCp-I-SUPF as the template and oligonucleotides listed in Table S1 . PCR products were digested with BamHI/XmaI to replace the Sup (1-61) fragment of pHIS-Sup35 (1-61)-GFP-Strep(II) and YEp-CUP1-Sup35 (1-61)-GFPStrep(II)-T (8) to obtain E. coli expression and yeast labeling vectors, respectively. Sup35 fragments were sequenced.
Proteins were overexpressed as GFP fusions in BL21(DE3)/pLysS and purified by Ni-NTA and StrepTactin affinity chromatography as described in refs. 8 and 34. Purified proteins were seeded immediately.
Infectivity Assay. Purified yeast prion particles (10 l in Buffer E, 0.3-1.0 M monomer concentration) were added to 200 l of purified Sup35 fragments (30 -100 M) to nucleate fiber growth at room temperature for 48 h quiescently. The fibers were sonicated on ice for 10 seconds with 6-W power output and then used to transform yeast by spheroplast fusion as described in ref. 8 . Transformed cells were subjected to [PSI] strain-typing as described in ref. 12 . Concentrations of different Sup35 fragments were normalized by GFP auto-fluorescence (excitation: 488 nm; emission: 507 nm). Three types of controls were included for yeast transformation: (i) Sup35 fragments alone, mock-seeded by 10 l of buffer E for 48 h and then sonicated; (ii) 10/210 dilution of the yeast seeds; and (iii) Buffer E alone. Fibers were subjected to SDS-polyacrylamide gel electrophoresis analysis to ensure correct monomer sizes.
For the measurement of specific infectivity, fibers were collected by centrifugation at 200,000 ϫ g on top of a 30% sucrose cushion (g ml Ϫ1 in Buffer W) for 2 h. The pellets were washed and resuspended in Buffer W and agitated by vortex and/or sonication to give similar fiber length distributions as measured by flow cytometry (10,000 events counted in a Becton-Dickinson FACS Calibur analyzer, using GFP auto-fluorescence; excitation: 488 nm; emission: 530 nm; 30-nm window). More than 95% of the fibers were single-stranded, as observed by electron microscopy. Equal amounts of fibers (normalized by total GFP fluorescence) were then used for yeast transformation. 
